IMMUNE-MEDIATED MOVEMENT DISORDERS: CLINICAL MANIFESTATIONS, TREATMENT, AND EVOLUTION. A MULTICENTER STUDY
Objective: To evaluate the clinical characteristics, etiologies, treatment, and evolution of patients with immune-mediated movement disorders(IMMD). Background: The highly variable and complex phenomenology of IMMD and…Azathioprine immunosuppression and disease modification in Parkinson’s disease (AZA-PD): a randomised double-blind placebo-controlled phase II clinical trial
Objective: To design a clinical trial to test the concept that the immune system is integral in the progression of Parkinson’s disease (PD) and establish…Tremor after organ transplantation: prevalence and characteristics
Objective: Here we report on the largest population of solid organ transplant recipients that was investigated with clinical neurophysiological methods, to objectively establish the tremor…Parkinson’s disease and chronic inflammatory demyelinating polyneuropathy with celiac disease: Improvement in neuropathy but not Parkinson’s symptoms after intravenous immunoglobulin and gluten free diet
Objective: To report a case of celiac disease in Parkinson's disease and CIPD, and examine the relationship. Background: Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) is a…Deep brain stimulation in two patients with immunosuppressive therapy
Objective: To report two patients with a movement disorder who underwent deep brain stimulation under concomitant immunosuppressive treatment. To report two patients with a movement…Inpatient vs outpatient workup of patients with ataxia and suspected paraneoplastic cerebellar degeneration: Does work-up location matter?
Objective: To assess the outcomes of patients with ataxia evaluated for paraneoplastic syndrome primarily in an outpatient or inpatient setting. Background: Although paraneoplastic ataxias are…Rare manifestation of CNS Lupus: Parkinsonism
Objective: To describe clinical and imaging features of a SLE patient who presented with parkinsonism which is a rare manifestation of NPSLE and the result…Development of a prototype alpha-synuclein vaccine to induce T regulatory cells for the treatment of synucleonopathy
Objective: Test the hypothesis that combining humoral and immunosuppressive cellular asyn immunization will enhance asyn clearance, and reduce inflammation and neuropathological symptoms in a human…Expanding the spectrum of Faciobrachial Dystonic Seizures
Objective: A 71 years old Italian man presented progressive dysarthria and involuntary movements. Background: Within two months he developed dysarthria, progressive homolateral oromandibular and arm dystonic posture, knee…Ninjurin 1 gene D110a single nucleotide polymorphism as a genetic marker for nerve damage leprosy patients from South India
Objective: Analyze the Ninjurin 1 gene single nucleotide polymorphisms in leprosy patients from south India, and the role of the gene in the nerve damage.…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.